IndraLab

Statements

reach
"In CMML, UTX mutations co-occurred with ASXL1, TET2, or CBL mutations, and in bladder cancer with somatic BAP1 mutations [75] and enhanced in vitro proliferation, in vivo tumor growth and cell migrati[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"
27151432
reach
"In CMML, UTX mutations co-occurred with ASXL1, TET2, or CBL mutations, and in bladder cancer with somatic BAP1 mutations [XREF_BIBR] and enhance in vitro proliferation, in vivo tumor growth and cell migration [XREF_BIBR]."
27151432